Company Name
Geron Corporation
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US3741631036
CIK:
0000886744
CUSIP:
374163103
Currency:
USD
Full Time Employees:
229
Phone:
650 473 7700
Website:
https://www.geron.com
Fiscal Year End:
December
IPO Date:
Jun 30, 1996
Description:
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Address:
919 East Hillsdale Boulevard, Foster City, CA, United States, 94404